港股异动 | CRO概念股涨幅居前美联储降息将利好CXO企业客户上海发文支持生物医药创新

智通财经08-02

智通财经APP获悉，CRO概念股早盘涨幅居前，截至发稿，昭衍新药(06127)涨5.08%，报7.65港元；泰格医药(03347)涨4.67%，报31.4港元；药明康德(02359)涨4.12%，报32.85港元；康龙化成(03759)涨4.11%，报9.87港元。消息面上，美联储表示，如果抗击通胀继续取得想要的进展，可能会在今年9月会议上宣布降息。有基金经理表示，短期来看，市场在交易美联储近期的...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2456341445?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-08-02 10:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2456341445","market":"us","top_or_hot":-1,"title":"港股异动 | CRO概念股涨幅居前 美联储降息将利好CXO企业客户 上海发文支持生物医药创新","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，CRO概念股早盘涨幅居前，截至发稿，昭衍新药(06127)涨5.08%，报7.65港元；泰格医药(03347)涨4.67%，报31.4港元；药明康德(02359)涨4.12%，报32.85港元；康龙化成(03759)涨4.11%，报9.87港元。消息面上，美联储表示，如果抗击通胀继续取得想要的进展，可能会在今年9月会议上宣布降息。有基金经理表示，短期来看，市场在交易美联储近期的...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1159112.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | CRO概念股涨幅居前 美联储降息将利好CXO企业客户 上海发文支持生物医药创新</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | CRO概念股涨幅居前 美联储降息将利好CXO企业客户 上海发文支持生物医药创新\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-02 10:03 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1159112.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，CRO概念股早盘涨幅居前，截至发稿，昭衍新药(06127)涨5.08%，报7.65港元；泰格医药(03347)涨4.67%，报31.4港元；药明康德(02359)涨4.12%，报32.85港元；康龙化成(03759)涨4.11%，报9.87港元。消息面上，美联储表示，如果抗击通胀继续取得想要的进展，可能会在今年9月会议上宣布降息。有基金经理表示，短期来看，市场在交易美联储近期的...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1159112.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4504","symbol_name":"桥水持仓","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1159112.html","article_id":"2456341445","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2456341445","pubTimestamp":1722564212,"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"消息面上，美联储表示，如果抗击通胀继续取得想要的进展，可能会在今年9月会议上宣布降息。有基金经理表示，短期来看，市场在交易美联储近期的降息预期，CXO企业的订单来自创新药公司，资金利率决定这些创新药公司能否很好地融资。此外，上海市政府印发《关于支持生物医药产业全链条创新发展的若干意见》，覆盖研发、支付等全链条。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"161726":"生物医药","399441":"生物医药","BK4504":"桥水持仓","CXO":"康休","BK4585":"ETF&股票定投概念","SSO":"两倍做多标普500ETF","BK4534":"瑞士信贷持仓","SDS":"两倍做空标普500ETF","BK4559":"巴菲特持仓","SPXU":"三倍做空标普500ETF","SH":"标普500反向ETF","OEX":"标普100",".SPX":"S&P 500 Index","BK4588":"碎股","SPY":"标普500ETF","OEF":"标普100指数ETF-iShares","IVV":"标普500指数ETF","BK4550":"红杉资本持仓","BK4581":"高盛持仓"},"translate_title":"Changes in Hong Kong stocks, CRO concept stocks are among the top gainers, the Federal Reserve's interest rate cut will benefit CXO corporate customers, Shanghai issues a document to support biomedical innovation","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"161726":0.6,"399441":0.6,"SH":0.6,"US912797HE00.BOND":0.6,"US912797GW17.BOND":0.6,"US912797GL51.BOND":0.6,"US912797GK78.BOND":0.6,"US7Y.BOND":0.6,"US6M.BOND":0.6,"US5Y.BOND":0.6,"US3Y.BOND":0.6,"US30Y.BOND":0.6,"US2Y.BOND":0.6,"US12M.BOND":0.6,"US10Y.BOND":0.6,"SSO":0.6,"SPY":0.6,"SPXU":0.6,".SPX":0.6,"SDS":0.6,"OEX":0.6,"OEF":0.6,"IVV":0.6,"ESmain":0.6,"CXO":0.6},"content_text":"智通财经APP获悉，CRO概念股早盘涨幅居前，截至发稿，昭衍新药(06127)涨5.08%，报7.65港元；泰格医药(03347)涨4.67%，报31.4港元；药明康德(02359)涨4.12%，报32.85港元；康龙化成(03759)涨4.11%，报9.87港元。消息面上，美联储表示，如果抗击通胀继续取得想要的进展，可能会在今年9月会议上宣布降息。有基金经理表示，短期来看，市场在交易美联储近期的降息预期，CXO企业的订单来自创新药公司，资金利率决定这些创新药公司能否很好地融资。由此，一旦市场降息，对CXO企业是一大利好。此外，上海市政府印发《关于支持生物医药产业全链条创新发展的若干意见》，覆盖研发、支付等全链条。湘财证券指出，此次上海发布支持医药产业全链条创新的意见出台是各地支持医药创新的重要体现，未来，创新药领域在新靶点、新机制、新结构等技术突破的相关公司将具有较大发展空间，而针对医疗服务板块，我们认为创新产业链CXO公司也将持续受益。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.28.3","shortVersion":"4.28.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2456341445"}

港股异动 | CRO概念股涨幅居前 美联储降息将利好CXO企业客户 上海发文支持生物医药创新

精彩评论

港股异动 | CRO概念股涨幅居前美联储降息将利好CXO企业客户上海发文支持生物医药创新